Sorry, I wasn't trying to imply that they should ramp up production. I have a hazy memory of someone on this board saying that they had done so before the CRL. I'm not making a judgement on whether that was the right thing to do or not. I am just trying to make some guesses on the number of patients that could be treated immediately if RemL was approved.
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-431
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |